USPTO serial 79393117
DINABIOS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 27, 2025
- Examiner
- BERNS, LEE ANNE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DINABIOS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alexander Montgomery
Alexander Montgomery Hinckley Allen & Snyder LLP28 State StreetPostfachBoston, MA 02109Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Active chemical ingredients used in the manufacture of medicines for treating heart and kidney diseases | ACTIVE | — |
| 005 | Pharmaceutical preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals in the nature of viral vectors; medicinal and biomedical preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals in the nature of viral vectors; Biological tissue cultures for medical use; Biological solid organ tissue intended for subsequent implantation; Surgical implants comprising living tissue; grafts, being implants, comprising living heart and kidney tissue; Biochemical preparations for medical use for the treatment of genetic diseases and cancer of solid organs, including heart and muscle diseases, liver diseases, kidney diseases, pancreas diseases, spleen diseases, lung diseases; Stem cells for medical use; pharmaceutical, medical, biomedical and veterinary preparations for the treatment of heart and kidney diseases | ACTIVE | — |
| 009 | Recorded and downloadable computer software and computer software platforms for data processing, storage, and analysis for the development of gene therapies; recorded and downloadable computer software and computer software platforms for data processing, storage, and analysis for use in medical, biomedical, veterinary and pharmaceutical research and development; scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signaling, detection, testing, inspection, and teaching apparatus and instruments in the nature of high speed cameras, electric sensors and electric actuators, optical 2D scanners, optical filters, and photomultiplier tubes for use in medical, biomedical, veterinary and pharmaceutical research and development; computers and data processing equipment intended for use in medical, biomedical, veterinary and pharmaceutical research and development | ACTIVE | — |
| 010 | Medical, surgical, paramedical, dental and veterinary apparatus and instruments, namely, apparatus and instruments for the treatment of genetic diseases and cancer of solid organs, including heart and muscle diseases, liver diseases, kidney diseases, pancreas diseases, spleen diseases, lung diseases; Medical instruments for the fusion of medicines, namely, syringes, infusion pumps, syringe systems comprising syringes and medical tubing for administering drugs, medical laboratory mixers, medical vial reconstitution mixers, nebulizers, medicine autoinjectors sold empty, and balloon catheters; Diagnostic apparatus for medical purposes, namely, for medical diagnostic testing related to heart and kidney diseases; infusion sets; medical and surgical implants made of artificial materials, namely, artificial heart and kidney synthetic tissue | ACTIVE | — |
| 035 | Advertising services; Commercial business administration, business organization consulting, and business management; providing office functions; commercial business management; consulting services regarding company management; company communication services, namely, public relations and providing business information for potential investors; consulting services relating to personnel management; personnel management; providing commercial information in the field of life science, health technology and medical technology; providing marketing information; drawing up of statements of accounts; retail store and wholesale store services featuring chemical and medical products and preparations, medical instruments and apparatus, and software in the medical field | ACTIVE | — |
| 042 | Software development and programming of software and computer software platforms for others for use in medical, biomedical, veterinary and pharmaceutical research and development; computer platform as a service (PAAS) for data processing, storage, and analysis in the fields of medical, biomedical, veterinary and pharmaceutical research and development; stem cell research services; consulting services relating to medical, biomedical, veterinary and pharmaceutical research and development; research and development services relating to medical, biomedical, veterinary and pharmaceutical preparations; providing information about medical, biomedical, veterinary and pharmaceutical scientific research and development; Biological research and analysis, namely, analysis of human tissue for medical, biomedical, veterinary and pharmaceutical research purposes; design and development of medical diagnostic apparatus; scientific research services with respect to the isolation and cultivation of human cells and tissues; programming of computer software for others for information platforms on the Internet for use in medical, biomedical, veterinary and pharmaceutical research and development; rental of laboratory apparatus and instruments for scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signaling, detection, testing, inspection and teaching purposes for use in medical, biomedical, veterinary and pharmaceutical research and development; rental of computer hardware and data processing equipment for use in medical, biomedical, veterinary and pharmaceutical research and development | ACTIVE | — |
| 044 | Providing medical information with respect to preparing and dispensing medications, in particular for cardiomyopathy, heart failure and kidney diseases; providing medical consultancy and medical information services in the field of medical care as it relates to medical, biomedical, veterinary and pharmaceutical products; genetic screening for medical, biomedical, veterinary and pharmaceutical purposes; human heart and kidney tissue bank services; medical services relating to the removal, treatment and processing of stem cells | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DiNABIOS AG
- Other trademarks owned by DiNABIOS AG
- Other trademarks owned by DiNABIOS AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named DINABIOS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 15, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 27, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 27, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 19, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 3, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 3, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 27, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 27, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 27, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 8, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 8, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 2, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 14, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 4, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 4, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 4, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 14, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 26, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 26, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 22, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 21, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 19, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 12, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 8, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 4, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |